Table 1.
Baseline characteristics.
| n = 52 Each Group | TAVI (n and Perc. or Mean ± SDM) | SURD-AVR (n and Perc. or Mean ± SDM) | p Value |
|---|---|---|---|
| female | 32 (62%) | 32 (62%) | |
| age, year | 77 ± 4.3 | 75 ± 4.0 | 0.051 |
| log. EuroScore I | 19 ± 12 | 17 ± 10 | 0.257 |
| STS Score | 4.48 ± 2.76 | 3.93 ± 2.59 | 0.339 |
| art. hypertension | 45 (87%) | 45 (87%) | |
| hyperlipidemia | 28 (54%) | 28 (54%) | |
| impaired LVF | 7 (13%) | 2 (4%) | 0.160 |
| renal insufficiency | 16 (31%) | 9 (17%) | 0.117 |
| previous MI | 8 (15%) | 5 (9.6%) | 0.371 |
| COPD | 18 (35%) | 15 (29%) | 0.527 |
| PAD | 15 (29%) | 8 (15%) | 0.98 |
| NYHA I-IV | 2.87 ± 0.44 | 2.67 ± 0.59 | 0.062 |
| emergency indication | 0 (0%) | 0 (0%) | |
| creatinine (mg/dL) | 1.29 ± 0.73 | 0.92 ± 0.40 | 0.002 |
| bilirubin (mg/dL) | 0.56 ± 0.35 | 0.62 ± 0.28 | 0.416 |
| BMI | 27.3 ± 5 | 28 ± 5 | 0.440 |
| diabetes | 21 (40%) | 22 (42%) | 0.971 |
| dialysis | 0 (0%) | 0 (0%) |
LVF, left ventricular function; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; PAD, peripheral arterial disease; NYHA, New York Heart Association classification; and BMI, body mass index.